Article Information
History
- April 12, 2022.
Article Versions
- Version 1 (February 14, 2022 - 19:12).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Teresa F. Pais1,*,
- Hajrabibi Ali1,
- Joana Moreira da Silva1,2,
- Nádia Duarte1,
- Rita Neres1,
- Chintan Chhatbar3,4,
- Rita C. Acúrcio5,
- Rita C. Guedes5,
- Maria Carolina Strano Moraes6,
- Bruno Costa Silva6,
- Ulrich Kalinke3 and
- Carlos Penha-Gonçalves1,*
- 1Instituto Gulbenkian de Ciência; Oeiras, Portugal
- 2CIISA, Faculdade de Medicina Veterinária, Universidade de Lisboa; Lisbon, Portugal
- 3Institute for Experimental Infection Research, TWINCORE, Centre for Experimental and Clinical Infection Research, a joint venture between the Helmholtz Centre for Infection Research and the Hannover Medical School; Hannover, Germany
- 4Institute of Neuropathology, Medical Faculty, University of Freiburg; Freiburg, Germany
- 5Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa; Lisbon, Portugal
- 6Systems Oncology Group, Champalimaud Research, Champalimaud Centre for the Unknown; Lisbon, Portugal
- ↵*Corresponding author. Email: mtpais{at}igc.gulbenkian.pt; cpenha{at}igc.gulbenkian.pt
Posted April 12, 2022.
Brain endothelial STING1 activation by Plasmodium-sequestered heme promotes cerebral malaria via type I IFN response
